Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Podcasts
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Research News
 
News Brief: Encenicline Enhances Cognition in Schizophrenia Study
28 June 2015. Encenicline, a drug that activates the nicotinic acetylcholine receptor, boosts cognition in schizophrenia...
 
Synaptic Genes Determine Brain Connectivity
23 June 2015. Coordinated activity within brain networks falters early in Alzheimer's disease and other disorders...
 
Rethinking Clozapine: Metabolite May Ease Cognitive Symptoms of Schizophrenia
15 June 2015. A new study supports the hypothesis that N-desmethylclozapine helps protect or enhance working memory in people with schizophrenia who are taking clozapine for psychosis...
 
 
 
 
Spotlight

Webinar on Schizotypy and Schizophrenia
Schizotypy is the collection of odd or abnormal thoughts and behaviors, sometimes quite mild, that resemble psychosis. Join us Monday, July 6, at 10 a.m. U.S. Eastern time for a webinar devoted to current thinking about this psychological construct and its relationship to schizophrenia. Our speakers and discussants will be Martin Debbane of the University of Geneva, Christine Mohr of the University of Lausanne, Mark Lenzenweger of the
State University of New York at Binghamton and Weill Cornell Medical College, Ulrich Ettinger of Bonn University, and Tyrone Cannon and David Glahn of Yale University.

Thanks to the Maryland Psychiatric Research Center and Oxford University Press, publishers of Schizophrenia Bulletin, we have open access to several articles on the topic, and our advisor Irving Gottesman has "penned" some introductory thoughts. We invite you help us fuel the webinar by leaving some preliminary comments. Image courtesy of Oxford University Press
Animal Models of Psychosis: What's the Value?
It seems that personalized stem cells from patients are all the rage for modeling psychiatric illnesses. So if we can one day turn these cells into little cerebral organoids (see SRF news report), what is the value and future of the various animal models that have been developed (e.g., the ones catalogued in the SRF Animal Models for Schizophrenia Research database)?
There's plenty of value left, according to an eminent group of experts who participated in an SRF-organized workshop on modeling psychosis in animals at the 2015 International Congress on Schizophrenia Research. We invite you to read the summary of the session and to submit your thoughts.

See comments by:
Schizophrenia Forum Radio Interviews Pat McGorry
Patrick McGorry
In Episode 2 of our new podcast feature, SRF Editor Hakon Heimer caught up with Patrick McGorry at the International Congress on Schizophrenia Research in Colorado Springs to talk about research in young people at very high risk of developing psychosis. In particular, we wanted to hear about the data from a large replication study of fish oil for the prevention of conversion to psychosis. There is also a digest of some of the recent significant news and discussion on SRF. You can listen to the podcast on the website, or subscribe as you would with any other podcasts that you listen to in the gym, in the car, on the train....
Welcome to the Schizophrenia Research Forum!
Welcome to the Schizophrenia Research Forum website—a virtual community for science about schizophrenia and related disorders. Our Mission is to help researchers in their quest for causes, improved treatments, and better understanding of schizophrenia. Read more about ways to browse the site.
 
What's New

Comments - Posted 29 June 2015
Read remarks by Stephen Marder about Keefe RS et al.
PAPER: Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an Alpha-7 Nicotinic Acetylcholine Receptor Agonist as a Treatment for Cognitive Impairment in Schizophrenia.
 
Comments - Posted 28 June 2015
Read remarks by Ullrich Bartsch about Berry JA et al.
PAPER: Sleep Facilitates Memory by Blocking Dopamine Neuron-Mediated Forgetting.
 
Comments - Posted 23 June 2015
Read remarks by Li-Huei Tsai, Sandra Siegert about Olde Loohuis NF et al.
PAPER: MicroRNA-137 Controls AMPA-Receptor-Mediated Transmission and mGluR-Dependent LTD.
 
Comments - Posted 23 June 2015
Read remarks by Stephan Taylor about Corcoran CM et al.
PAPER: Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective.
 
Comments - Posted 23 June 2015
Read remarks by Martine Jaworski about Pocklington AJ et al.
PAPER: Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia.
 
Comments - Posted 17 June 2015
Read remarks by J. Daniel Ragland about Satterthwaite TD et al.
PAPER: Connectome-wide network analysis of youth with Psychosis-Spectrum symptoms.
June 30, 2015
SRF News
SRF Comments
Text Size
Reset Text Size
Share/Bookmark

Check out our upcoming webinar, How Can Schizotypy Inform Schizophrenia Research?, on Monday, July 6, at 10 a.m. U.S. EST.

See our ongoing Forum Discussion, Prediction Error: The Genesis of Delusions?.
New Schizophrenia Fact Sheet for Patients and Families

Latest BBRF Research Breakthroughs

Visit our Facebook page and our Blog.

Support the Brain & Behavior Research Foundation Today.
SZGene
AlzGene
MSGene
PDGene
An up-to-date collection of all published genetic association studies.
A community resource created by Jim Koenig, University of Maryland.
We invite your comments and suggested edits to these facts about schizophrenia.
Compiled by Angus MacDonald, S. Charles Schulz, and the Minnesota Consensus Group.
NIH BRAIN Initiative Multi-Council Working Group Meeting-July 2015: Thursday, July 30, 2015, 8:00 a.m.

Research Participants
Collaborators
Copyright © 2005- 2015 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright